November 10, 2020, at 09:00 CET/ 16:00 TPE time
Zoom Virtual Meeting
In this one-hour webinar, Novartis Global, Novartis Taiwan and European Taiwan Biotech Association (ETBA) will discuss this challenge in detailed, including an introduction of the challenge, the technology Novartis Institutes for BioMedical Research (NIBR) is looking for and the perspective of the collaboration of using your technology. In addition, an expert in the digital biomarker field will share his experience on product development from research to market launch. Please join us for this insightful webinar and we will be happy to answer your questions that you may have.
- Michael Kangas, Director Regional Partnerships, Novartis Institutes for BioMedical Research
- David Lee, Ph.D., Chief Scientific Officer, Novartis Taiwan
- Ti-Hao Wang, M.D., Director of Research and Development, EverFortune.AI
- Melody Huang, VP, Europe-Taiwan Biotech Association
The webinar recording can be requested until November 30, 2020, at 11:00 CET / 18:00 TPE time.